Get the Stockscreener App
1.61
8.52%
-0.15
Pre-market:
1.60
-0.01
-0.62%
Invivyd Inc stock is traded at $1.61, with a volume of 3.69M.
It is down -8.52% in the last 24 hours and up +38.79% over the past month.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
See More
Previous Close:
$1.76
Open:
$1.8
24h Volume:
3.69M
Relative Volume:
0.53
Market Cap:
$193.43M
Revenue:
-
Net Income/Loss:
$-225.14M
P/E Ratio:
-0.8214
EPS:
-1.96
Net Cash Flow:
$-192.27M
1W Performance:
-25.12%
1M Performance:
+38.79%
6M Performance:
+156.21%
1Y Performance:
+76.23%
1-Day Range:
$1.60
$1.88
1-Week Range:
$1.60
$2.24
52-Week Range:
$0.3546
$2.74
Invivyd Inc Stock (IVVD) Company Profile
Name
Invivyd Inc
Sector
Industry
Phone
(781) 819-0080
Address
1601 TRAPELO ROAD, WALTHAM
Compare IVVD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IVVD
Invivyd Inc
|
1.61 | 377.36M | 0 | -225.14M | -192.27M | -1.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Invivyd Inc Stock (IVVD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-06-25 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-05-24 | Upgrade | Guggenheim | Neutral → Buy |
| Mar-26-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-19-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-01-23 | Initiated | H.C. Wainwright | Buy |
Invivyd Inc Stock (IVVD) Latest News
Is Invivyd Inc. stock vulnerable to regulatory risksEarnings Beat & Technical Pattern Alert System - newser.com
HC Wainwright & Co. Maintains Invivyd (IVVD) Buy Recommendation - Nasdaq
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025 - The Manila Times
H.C. Wainwright doubles Invivyd stock price target to $10 on COVID-19 program - Investing.com
Custom strategy builders for tracking Invivyd Inc.Weekly Stock Recap & Stepwise Trade Signal Guides - newser.com
Can Invivyd Inc. stock deliver consistent earnings growthBull Run & Real-Time Volume Spike Alerts - newser.com
Invivyd Inc. stock momentum explained2025 Technical Overview & Safe Entry Zone Identification - newser.com
Using economic indicators to assess Invivyd Inc. potentialMarket Growth Report & Reliable Price Action Trade Plans - newser.com
What is the fair value of Invivyd Inc. stock now2025 Market Overview & Comprehensive Market Scan Insights - newser.com
Invivyd Inc. stock volume spike explainedPortfolio Risk Summary & Real-Time Market Trend Scan - newser.com
Will Invivyd Inc. stock gain from strong economyGlobal Markets & Detailed Earnings Play Alerts - newser.com
How institutional buying supports Invivyd Inc. stock2025 Top Decliners & Growth Focused Stock Reports - newser.com
Backtesting results for Invivyd Inc. trading strategiesMarket Activity Report & Free Daily Entry Point Trade Alerts - newser.com
Real time pattern detection on Invivyd Inc. stockJuly 2025 News Drivers & Short-Term High Return Strategies - newser.com
Visual trend scoring systems applied to Invivyd Inc.July 2025 Update & Consistent Profit Alerts - newser.com
Why analysts upgrade Invivyd Inc. stockJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
Why Invivyd Inc. stock is popular among millennialsStock Surge & Breakout Confirmation Trade Signals - newser.com
What drives Invivyd Inc stock priceHead and Shoulders Patterns & Set Your Capital Stop-Loss Limits Effectively - earlytimes.in
Invivyd (NASDAQ:IVVD) Receives "Sell (E+)" Rating from Weiss Ratings - MarketBeat
Invivyd, Inc. (NASDAQ:IVVD) Short Interest Up 156.9% in October - MarketBeat
Invivyd price target raised to $10 from $5 at H.C. Wainwright - MSN
H.C. Wainwright Maintains Invivyd(IVVD.US) With Buy Rating, Raises Target Price to $10 - 富途牛牛
Invivyd (IVVD) Analyst Rating: HC Wainwright Raises Price Target to $10 | IVVD Stock News - GuruFocus
Invivyd Highlights Antibody Development in New Presentation - MSN
Invivyd (IVVD) Price Target Increased by 88.89% to 5.78 - MSN
Candlestick signals on Invivyd Inc. stock todayOil Prices & High Yield Stock Recommendations - newser.com
Invivyd, Inc. (NASDAQ:IVVD) Given Average Rating of "Hold" by Brokerages - MarketBeat
[8-K] Invivyd, Inc. Reports Material Event | IVVD SEC FilingForm 8-K - Stock Titan
Invivyd, Inc. (IVVD) Discusses REVOLUTION Clinical Program and Development of VYD2311 Antibody for COVID PreventionSlideshow (NASDAQ:IVVD) 2025-10-30 - Seeking Alpha
Invivyd Inc Stock (IVVD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):